NEW YORK (Reuters Health) – In the PRIMO trial, treatment with vitamin D2 (paricalcitol) did not improve measures of cardiac structure, function or left ventricular mass in patients…
NEW YORK (Reuters Health) – Even a few hours a night of continuous positive airway pressure (CPAP) therapy leads to meaningful improvements in attention, sleepiness and quality of…
NEW YORK (Reuters Health) – Results of a population-based observational study indicate that androgen deprivation therapy (ADT) for men with nonmetastatic prostate cancer is associated with an increased…
NEW YORK (Reuters Health) – The glucagon-like peptide 1 analog taspoglutide administered subcutaneously once weekly improves glycemic control and reduces body weight in drug-naive patients with type 2…
NEW YORK (Reuters Health) – Abnormalities seen on brain CT with CT angiography (CTA) soon after a transient ischemic attack or minor stroke predict the risk of a…
NEW YORK (Reuters Health) – While treatment of several malignancies with VEGFR (vascular endothelial growth factor receptor) tyrosine kinase inhibitors has improved patient outcomes, the agents are associated…
NEW YORK (Reuters Health) – Most domains of health-related quality of life in iron-deficient patients with chronic heart failure improve significantly after 4 weeks of treatment with intravenous…
NEW YORK (Reuters Health) – There is less risk of growth failure in human milk-fed premature infants when they’re given a human milk fortifier with extra protein, Australian…
NEW YORK (Reuters Health) – Patients and health care workers (HCWs) with symptomatic nosocomial norovirus (NoV) infection are much more apt to transmit the virus than asymptomatic shedders,…
NEW YORK (Reuters Health) – For women with proven stress urinary incontinence, tension-free vaginal tape provides lasting relief, according to results of a 10-year follow-up study conducted in…
NEW YORK (Reuters Health) – In a controlled study, clinicians didn’t see any benefit to treating patent ductus arteriosus (PDA) early (as soon as mild PDA symptoms appear)…
NEW YORK (Reuters Health) – If lifestyle changes are not enough to control type 2 diabetes, metformin should be the first oral agent added to treatment, according to…
